Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Mechanisms of Endothelial Dysfunction and Cardiovascular System Adaptation

Author(s): Luis Sobrevia, Ernesto Alejandro Aiello and Paola Contreras

Volume 20, Issue 3, 2022

Published on: 25 August, 2022

Page: [201 - 204] Pages: 4

DOI: 10.2174/157016112003220825112123

Next »
[1]
World Health Organization. Cardiovascular diseases (CVDs). 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) [last accessed August 12, 2022]
[2]
Sobrevia L. Glycaemia dynamics concepts before and after insulin. Biochem Pharmacol 2022; 201: 115092.
[http://dx.doi.org/10.1016/j.bcp.2022.115092]
[3]
García RD, Asensio JA, Perdicaro DJ, de los Ángeles Peral M. The role of inflammation as a preponderant risk factor in cardiovascular diseases. Curr Vasc Pharmacol 2022.
[http://dx.doi.org/10.2174/1570161120666220201160038]
[4]
Mann GE, Yudilevich DL, Sobrevia L. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 2003; 83(1): 183-252.
[http://dx.doi.org/10.1152/physrev.00022.2002]
[5]
Freitas RA, Lima VV, Bomfim GF, Giachini FRC. Interleukin-10 in the vasculature: pathophysiological implications. Curr Vasc Pharmacol 2021.
[http://dx.doi.org/10.2174/1570161120666211227143459]
[6]
Gao A, Van Dyke TE. Role of suppressors of cytokine signaling 3 in bone inflammatory responses. Front Immunol 2014; 4: 506.
[http://dx.doi.org/10.3389/fimmu.2013.00506]
[7]
Cabalín C, Villalobos-Labra R, Toledo F, Sobrevia L. Involvement of A2B adenosine receptors as anti-inflammatory in gestational diabesity. Mol Aspects Med 2019; 66: 31-9.
[http://dx.doi.org/10.1016/j.mam.2019.01.001]
[8]
Cornejo M, Fuentes G, Valero P, et al. Gestational diabesity and foetoplacental vascular dysfunction. Acta Physiol (Oxf) 2021; 232(4): e13671.
[http://dx.doi.org/10.1111/apha.13671]
[9]
Giachini FR, Zemse SM, Carneiro FS, Lima VV, Carneiro ZN, Callera GE, et al. Interleukin-10 attenuates vascular responses to endothelin-1 via effects on ERK1/2-dependent pathway. Am J Physiol 2009; 296(2): H489-96.
[http://dx.doi.org/10.1152/ajpheart.00251.2008]
[10]
Qiu M, Shu H, Li L, Shen Y, Tian Y, Ji Y, et al. Interleukin 10 attenuates angiotensin II-induced aortic remodelling by inhibiting oxidative stress-induced activation of the vascular p38 and NF-κB pathways. Oxid Med Cell Longev 2022; 2022: 8244497.
[http://dx.doi.org/10.1155/2022/8244497]
[11]
Luna-Ceron E, González-Gil AM, Elizondo-Montemayor L. Current insights on the role of irisin in endothelial dysfunction. Curr Vasc Pharmacol 2022; 3: 205-20.
[http://dx.doi.org/10.2174/1570161120666220510120220]
[12]
Raschke S, Eckel J. Adipo-myokines: two sides of the same coin--mediators of inflammation and mediators of exercise. Mediators Inflamm 2013; 2013: 320724.
[http://dx.doi.org/10.1155/2013/320724]
[13]
Casanello P, Escudero C, Sobrevia L. Equilibrative nucleoside (ENTs) and cationic amino acid (CATs) transporters: implications in foetal endothelial dysfunction in human pregnancy diseases. Curr Vasc Pharmacol 2007; 5(1): 69-84.
[http://dx.doi.org/10.2174/157016107779317198]
[14]
Janaszak-Jasiecka A, Siekierzycka A, Płoska A, Dobrucki IT, Kalinowski L. Endothelial dysfunction driven by hypoxia-the influence of oxygen deficiency on NO bioa-vailability. Biomolecules 2021; 11(7): 982.
[http://dx.doi.org/10.3390/biom11070982]
[15]
Casanello P, Sobrevia L. Intrauterine growth retardation is associated with reduced activity and expression of the cationic amino acid transport systems y+/hCAT-1 and y+/hCAT-2B and lower activity of nitric oxide synthase in human umbilical vein endothelial cells. Circ Res 2002; 91(2): 127-34.
[http://dx.doi.org/10.1161/01.res.0000027813.55750.e7]
[16]
Castillo-Galán S, Arenas GA, Iturriaga R. Contribution of STIM-activated TRPC-ORAI channels in pulmonary hypertension induced by chronic sustained and intermit-tent hypoxia. Curr Vasc Pharmacol 2022; 20(3): 272-83.
[http://dx.doi.org/10.2174/1570161120666220321141805]
[17]
Wu M-Y, Yiang G-T, Liao W-T, et al. Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem 2018; 46(4): 1650-67.
[http://dx.doi.org/10.1159/000489241]
[18]
Valdés-Jorquera R, Oviedo-Castro L, Oliva CA, Mariqueo TA. Role of glycine and glycine receptors in vascular endothelium: a new perspective for the management of the post-ischemic injury. Curr Vasc Pharmacol 2022; 20(3): 225-9.
[http://dx.doi.org/10.2174/1570161120666220720101352]
[19]
Garza-González S, Nieblas B, Solbes-Gochicoa MM, Altamirano J, García N. Intermittent fasting as possible treatment for heart failure. Curr Vasc Pharmacol 2022; 20(3): 260-71.
[http://dx.doi.org/10.2174/1570161120666220610151915]
[20]
Villalobos-Labra R, Subiabre M, Toledo F, Pardo F, Sobrevia L. Endoplasmic reticulum stress and development of insulin resistance in adipose, skeletal, liver, and foe-toplacental tissue in diabesity. Mol Aspects Med 2019; 66: 49-61.
[http://dx.doi.org/10.1016/j.mam.2018.11.001]
[21]
Howlett LA, Jones SA, Lancaster MK. Pharmacy and exercise as complimentary partners for successful cardiovascular ageing. Curr Vasc Pharmacol 2022; 20(3): 284-302.
[http://dx.doi.org/10.2174/1570161120666220107105840]
[22]
Alcántara-Zapata D, Nazzal C, Muñoz S, De Gregorio N, Marchetti N, Behn C. Varicocele at high altitude. Venous outflow restriction by hypobaric hypoxia? Curr Vasc Pharmacol 2022; 20(3): 303-9.
[http://dx.doi.org/10.2174/1570161120666220510120831]
[23]
Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol 2018; 14(10): 576-90.
[http://dx.doi.org/10.1038/s41574-018-0059-4]

Rights & Permissions Print Cite
Article Metrics
36
2
© 2024 Bentham Science Publishers | Privacy Policy